YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. Funds and ETFs YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Equities
1558
CNE1000023R6
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.86 HKD | +0.47% |
|
+7.53% | +35.51% |
| Apr. 09 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
| Apr. 01 | Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps | MT |
ETFs positioned on YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.22% | 4 M€ | -27.92% | ||
| 0.00% | 34 M€ | +2.14% | - |
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceutical products. The Company is also engaged in the research and development, marketing and distribution of pharmaceuticals. The products of the Company include anti-viral drugs, endocrine and metabolic drugs and cardiovascular drugs. Its main products include Kewei, Ertongshu, Oumeining, Xinhaining and Xining.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.85
CNY
Average target price
12.94
CNY
Spread / Average Target
+9.22%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +35.51% | 1.44B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 1558 Stock
- Funds and ETFs YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
